2021 American Transplant Congress
Center Cost is Not a Barrier to Aggressive Utilization of DCD Livers
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Only 7% of livers transplanted in 2018 were from deceased from cardiac death (DCD) donors and only a minority of transplant centers aggressively utilize…2021 American Transplant Congress
Covid-19 in Renal Transplant Recipients: Experience of Lithuania
Nephrology, Vilnius University Santaros clinics, Vilnius, Lithuania
*Purpose: Renal transplant recipients are at increased susceptibility to many viral infections, including coronavirus disease 2019 (COVID-19). The purpose of this review is to define…2021 American Transplant Congress
Extreme Hyponatremia as a Risk Factor for Early Mortality After Liver Transplantation in the MELD-Sodium Era
*Purpose: The impact of hyponatremia on waitlist and post-transplant outcomes following the implementation of MELD-Na based liver allocation remains unclear. We sought to evaluate waitlist…2021 American Transplant Congress
Human Leukocyte Antigen Mismatches Between Donor-Recipient or Donor-Donor are Not Associated with Adverse Pancreas Outcomes in Pancreas After Kidney Transplant Recipients
University of Wisconsin, MADISON, WI
*Purpose: A greater degree of HLA mismatch has been previously associated with inferior graft survival in kidney and pancreas transplantation. Pancreas after kidney (PAK) recipients…2021 American Transplant Congress
Achilles Heel No Longer: Marked Decline in Early Relaparotomy and Allograft Pancreatectomy Rates Following Simultaneous Kidney-Pancreas Transplantation in the Contemporary Era
*Purpose: Technical complications requiring early relaparotomy (relap) and allograft pancreatectomy (AP) have long been the Achilles heel of simultaneous kidney-pancreas transplantation (SKPT).*Methods: Single center retrospective…2021 American Transplant Congress
Comparison of Outcomes of Living Donor Liver Transplantation for Biliary Atresia Patients with and without Kasai Portoenterostomy
*Purpose: We evaluated 10 year outcomes and the potential predictors of outcomes after living donor liver transplant (LT) for biliary atresia (BA) patients with and…2021 American Transplant Congress
Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation
Mayo Clinic Rochester, Minnesota, Rochester, MN
*Purpose: Renal dysfunction at the time of listing predicts inferior waitlist outcomes in pediatric liver transplant candidates, independent of the Pediatric End-Stage Liver Disease (PELD)…2021 American Transplant Congress
Assessing Liver Transplant Outcomes Utilizing Post-Cross Clamp Offers
1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic Alix School of Medicine, Scottsdale, AZ
*Purpose: With the ongoing organ shortage, there has been increased interest in utilizing post-cross clamp (XC) liver allografts as a means of expanding the donor…2021 American Transplant Congress
Peripheral Lymphocyte Profiling and Increased Risk of EBV Infection in Pediatric Liver Transplant Recipients
*Purpose: Epstein-Barr virus “EBV” infection and post-transplant lymphoproliferative disorders “PTLD” are significant comorbidities in the post-transplant “PT” setting, especially in pediatrics. The synergy among T…2021 American Transplant Congress
Liver Transplantation with Super Obese Donors (BMI≥50) Grafts: An Acceptable Pathway to Expand the Donor Pool. Analysis of the OPTN/UNOS Liver Transplant Registry
*Purpose: We aimed to analyze the impact of donor body mass index (BMI) on recipient morbidity and survival following liver transplantation (LT).*Methods: The UNOS-STAR database…
- « Previous Page
- 1
- …
- 218
- 219
- 220
- 221
- 222
- …
- 1683
- Next Page »